Fingerprint
Dive into the research topics of 'The role of imatinib mesylate (Glivec) for treatment of patients with malignant endocrine tumors positive for c-kit or PDGF-R'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
The role of imatinib mesylate (Glivec) for treatment of patients with malignant endocrine tumors positive for c-kit or PDGF-R
David J. Gross*, Gabriel Munter, Menachem Bitan, Tali Siegal, Alberto Gabizon, Ronny Weitzen, Ofer Merimsky, Aliza Ackerstein, Asher Salmon, Avishai Sella, Shimon Slavin
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
130
Scopus
citations